Structure-Based Design of an in Vivo Active Selective BRD9 InhibitorLaetitia J. Martin, Darryl B. McConnell, Thomas Gerstberger et al.|Journal of Medicinal Chemistry|2016Cited by 227
Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of CancerChristian A. Kuttruff, Thorsten Oost, Martin Fleck et al.|Journal of Medicinal Chemistry|2023Cited by 15
Abstract 4522: Potent induction of a tumor-specific immune response by a cyclic dinucleotide STING agonistGabriela Gremel, Norbert Kraut, Maria Antonietta Impagnatiello et al.|Cancer Research|2020Cited by 5